Gastro-oesophageal reflux disease - Treatment with doxycycline Factor
Doxycycline belongs to the tetracycline class of antibiotics.
Common Australian brand names include Doxycycline, Doxsig, Doryx, Doxylin and Vibramycin.
Within the ADF, doxycycline is often prescribed as a malaria prophylactic. It provides for specific coverage against malaria caused by P. vivax. However, there are relatively few locations where P. vivax does not coexist to some extent with P. falciparum, it is generally recommended that doxycycline be taken in conjunction with other antimalarial agents such as chloroquine. If a person served in an area of malarial transmission it is very unlikely that the provision of anti-malarials would be recorded in the service medical records. Therefore, the absence of such documentation should not be regarded as evidence that anti-malarial drugs were not provided.
The drug is otherwise prescribed for infections due to susceptible organisms including primary atypical pneumonia, typhus fever, Q fever, psittacosis, granuloma inguinale, relapsing fever, trachoma, cholera, brucellosis, plague, venereal diseases and severe acne. It may also be prescribed for other recalcitrant medical conditions such as tonsillitis or rheumatoid arthritis.
Last reviewed for CCPS 18 July 2005.
Investigative Documents
| Type | Title | PDF Format | Word Format |
|---|---|---|---|
| Claimant Report | Treatment with doxycycline - Gastro-Oesophageal Reflux Disease | ||
| Medical Report | Non-steroidal Anti-inflammatory Drugs and/or Doxycycline -Gastro-Oesophageal Reflux Disease |
Preliminary questions [34902]
7334 the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.
7335 the condition under consideration permanently worsened.
34907 the veteran has established the causal connection between the treatment with doxycycline and operational service for the clinical worsening of gastro-oesophageal reflux disease.
Clinical worsening and operational service [34907]
35134 as a consequence of operational service, the veteran was treated with doxycycline.
35135 as a consequence of operational service, the veteran was treated with doxycycline at the time of the clinical worsening of the condition under consideration.
or
34905 the veteran was treated with doxycycline for treatment of an illness or injury which is identifiable.
34904 for treatment of the identified illness or injury, the veteran was treated with doxycycline at the time of the clinical worsening of the condition under consideration.
34906 the identified illness or injury, for which the veteran was being treated with doxycycline at the time of the clinical worsening of the condition under consideration, is a condition for which the drug cannot be ceased or substituted.
34908 the identified illness or injury which required treatment with doxycycline is causally related to operational service.
34909 the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury which required treatment with doxycycline is causally related.